Latest filing published 12 Nov 2025 for Certara, Inc., €173k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
William F. Feehery (chief executive) discloses dealings in 2 companies, chiefly Certara, Inc. and West Pharmaceutical Services Inc. Between 4 May 2021 and 11 November 2025, the trades on record add up to 26 filings.
In open-market terms, that means 1 purchase worth €173k on one side and 15 sales worth €21.9M on the other. Sales outweigh purchases by €21.7M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 10 share grants. Since January 2025: 1 purchase and no sales on the market.
Most recently, on 12 November 2025, the filings show an open-market purchase worth €173k in Certara, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 26 declarations